Adage Capital Partners
AXSM icon

Adage Capital Partners’s Axsome Therapeutics AXSM Stock Holding History

Adage Capital Partners’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$125M Buy
737,578
+370,000
+101% +$63.9M 0.19% 99
2025
Q4 		$67.1M Sell
367,578
-77,422
-17% -$10.8M 0.1% 193
2025
Q3 		$54M Sell
445,000
-2,000
-0.4% -$225K 0.09% 223
2025
Q2 		$46.7M Buy
447,000
+399,000
+831% +$42.2M 0.08% 251
2025
Q1 		$5.6M Sell
48,000
-12,000
-20% -$1.37M 0.01% 682
2024
Q4 		$5.08M Sell
60,000
-465,000
-89% -$42.8M 0.01% 716
2024
Q3 		$47.2M Sell
525,000
-205,000
-28% -$17.9M 0.08% 243
2024
Q2 		$58.8M Buy
730,000
+215,000
+42% +$15.9M 0.11% 193
2024
Q1 		$41.1M Buy
515,000
+150,000
+41% +$12.6M 0.08% 273
2023
Q4 		$29.1M Buy
365,000
+40,000
+12% +$2.67M 0.06% 329
2023
Q3 		$22.7M Sell
325,000
-119,417
-27% -$8.93M 0.05% 360
2023
Q2 		$31.9M Sell
444,417
-605,583
-58% -$44.7M 0.07% 283
2023
Q1 		$64.8M Sell
1,050,000
-15,000
-1% -$985K 0.15% 169
2022
Q4 		$82.1M Buy
1,065,000
+915,000
+610% +$54.7M 0.2% 128
2022
Q3 		$6.69M Sell
150,000
-633,662
-81% -$31.7M 0.02% 738
2022
Q2 		$30M Buy
783,662
+133,662
+21% +$4.23M 0.07% 300
2022
Q1 		$26.9M Buy
+650,000
New +$20.1M 0.05% 373
2020
Q4 		– Sell
-200,000
Closed -$14.3M – 809
2020
Q3 		$14.3M Hold
200,000
– – 0.04% 457
2020
Q2 		$16.5M Buy
200,000
+115,000
+135% +$8.85M 0.04% 430
2020
Q1 		$5M Buy
+85,000
New +$6.93M 0.01% 571

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners's AXSM Position: Q1 2026 in Review

Adage Capital Partners increased its Axsome Therapeutics (AXSM) stake by 101% in Q1 2026, buying an estimated $63.9M and bringing the position to 737,578 shares worth $125M. The position accounts for 0.19% of the portfolio, ranked #99.

Adage Capital Partners first reported a position in AXSM in Q1 2020 and has held it in 20 quarters since. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Adage Capital Partners held 737,578 shares of Axsome Therapeutics worth $125M as of Q1 2026.
  • Adage Capital Partners bought 370,000 Axsome Therapeutics shares in Q1 2026, an estimated $63.9M.
  • Axsome Therapeutics made up 0.19% of Adage Capital Partners's portfolio in Q1 2026, its #99 holding.
  • Adage Capital Partners first reported a position in Axsome Therapeutics in Q1 2020 and has held it in 20 quarters since.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.